Showing results (131-140 of 151) with videos related to
Sort By:
Pageof 16
Cardiovascular Drug Reviews|June 5, 2004
Low-molecular-weight heparins in thrombosis and cancer: emerging linksShaker A MousaCardiovascular Drug Reviews|June 5, 2004
Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current statusStefano Fiorucci, Elisabetta Antonelli, Paola Tocchetti, et al.Cardiovascular Drug Reviews|May 4, 2005
The preclinical pharmacology of BIBN4096BS, a CGRP antagonistDebbie L Hay, David PoynerCardiovascular Drug Reviews|October 20, 2004
Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivololAlexey Kuroedov, Francesco Cosentino, Thomas F LüscherCardiovascular Drug Reviews|December 15, 2007
Serofendic acid, a substance extracted from fetal calf serum, as a novel drug for cardioprotectionMasaharu Akao, Toshihiro Takeda, Toru Kita, et al.Cardiovascular Drug Reviews|December 15, 2007
A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillationHikaru Tanaka, Norio HashimotoCardiovascular Drug Reviews|December 15, 2007
Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profileJoseph A Jakubowski, Kenneth J Winters, Hideo Naganuma, et al.Cardiovascular Drug Reviews|April 15, 2006
Hypoxic pulmonary hypertension (HPH) and iptakalim, a novel ATP-sensitive potassium channel opener targeting smaller arteries in hypertensionHai Wang, Yuan Tang, Ying-Li ZhangCardiovascular Drug Reviews|August 31, 2006
Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K ChannelsNoriyoshi TeramotoCardiovascular Drug Reviews|August 31, 2006
Ambrisentan, a non-peptide endothelin receptor antagonistHartmut Vatter, Volker SeifertPageof 16